Safety and efficacy of SNS-301 plus pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Algazi, Alain Patrick
Smith, William
Bruce, Justine Yang
Shin, Dong Moon
Gramza, Ann Wild
Jelinek, Michael J.
Singh, Jaswinder
Misiukiewicz, Krzysztof
Shah, Dhaval
Campbell, Jean S.
Pierce, Robert Hamilton
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] NOCCR VRG, Knoxville, TN USA
[3] Univ Wisconsin, Madison, WI USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[6] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[7] Res Med Ctr, Mission Hills, KS USA
[8] Icahn Sch Med Mt Sinai, Hematol & Med Oncol, New York, NY 10029 USA
[9] Med Oncol Hematol Consultants, Newark, DE USA
[10] Sensei Biotherapeut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18009
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SNS-301 added to pembrolizumab in patients (Pts) with ASPH plus advanced squamous cell carcinoma of the head & neck (SCCHN)
    Algazi, A. P.
    Guarino, M.
    Panella, T. J.
    Celebi, J.
    Csiki, I.
    Drumheller, A.
    Campbell, J.
    Pierce, R.
    Smith, W. B.
    ANNALS OF ONCOLOGY, 2020, 31 : S666 - S666
  • [2] Update on safety and efficacy of a phase 1/2 of SNS-301 added to pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN).
    Algazi, Alain Patrick
    Shah, Dhaval
    Smith, William
    Panella, Timothy J.
    Shin, Dong Moon
    Bruce, Justine Yang
    Melhem, Ramzi
    Campbell, Jean S.
    Abell, Lauren
    Fjaellskog, Marie-Louise
    Celebi, John K.
    Pierce, Robert Hamilton
    Gramza, Ann Wild
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Safety/efficacy of a phase I/II study of SNS-301 added to pembrolizumab in patients with ASPH plus locally advanced unresectable or metastatic/recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Smith, William
    Celebi, John
    Pierce, Robert
    Drumheller, Alice
    Csiki, Ildiko
    Algazi, Alain Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] EARLY SAFETY AND EFFICACY OF A PHASE 1/2 OPEN-LABEL, MULTI-CENTER TRIAL OF SNS-301 ADDED TO PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Algazi, Alain
    Smith, William
    Panella, Timothy
    Shin, Dong
    Fjaellskog, Marie-Louise
    Celebi, John
    Drumheller, Alice
    Campbell, Jean
    Pierce, Robert
    Guarino, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A213 - A214
  • [5] Safety of pembrolizumab with chemoradiation (CRT) in locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
    Powell, Steven Francis
    Gitau, Mark Mutuota
    Sumey, Christopher Joseph
    Reynolds, John T.
    Lohr, Michele
    McGraw, Steven
    Nowak, Ryan Kenneth
    Terrell, Andrew M.
    Jensen, Ashley Wayne
    Blanchard, Miran Joel
    Ellison, Christie
    Black, Lora Jane
    Thompson, Paul A.
    Gold, Kathryn A.
    Cohen, Ezra E. W.
    Lee, John H.
    Spanos, William Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
    Matsuo, Mioko
    Masuda, Muneyuki
    Yamauchi, Moriyasu
    Taura, Masahiko
    Hashimoto, Kazuki
    Kogo, Ryunosuke
    Jiromaru, Rina
    Hongo, Takahiro
    Manako, Tomomi
    Nakagawa, Takashi
    IN VIVO, 2023, 37 (05): : 2188 - 2196
  • [7] Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
    Powell, Steven F.
    Gold, Kathryn A.
    Gitau, Mark M.
    Sumey, Christopher J.
    Lohr, Michele M.
    McGraw, Steven C.
    Nowak, Ryan K.
    Jensen, Ashley W.
    Blanchard, Miran J.
    Fischer, Christopher D.
    Bykowski, Julie
    Ellison, Christie A.
    Black, Lora J.
    Thompson, Paul A.
    Callejas-Valera, Juan L.
    Lee, John H.
    Cohen, Ezra E. W.
    Spanos, William C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (21) : 2427 - +
  • [8] Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
    Johnson, Jennifer Maria
    Bar Ad, Voichita
    Lorber, Emily
    Poller, Dawn
    Luginbuhl, Adam
    Curry, Joseph M.
    Cognetti, David M.
    Keith, Scott W.
    Axelrod, Rita Susan
    Zinner, Ralph
    Rodeck, Ulrich
    Harshyne, Larry
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Individualized therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Kies, M.
    ORAL ONCOLOGY, 2009, : 9 - 10
  • [10] Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.
    Li, Jieying
    Song, Kai
    Feng, Yuanyong
    Shang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18001 - E18001
12345